Lipoproteoplex (IMAGE)
Caption
A new hybrid compound called a lipoproteoplex, developed in the lab at the NYU Tandon School of Engineering, uses a lipid "container" for transfection -- the transportation of material past a cell membrane -- and an easy-to-make protein capsule that can bind both small-molecule chemotherapeutic drugs and genetic technology, such as short interfering RNA (siRNA), that can "silence" genes that propagate disease states.
Credit
NYU Tandon
Usage Restrictions
None
License
Licensed content